Correspondence: Cardiovascular risk factors among forensic patients in the acute psychiatric ward [1]

Australian and New Zealand Journal of Psychiatry

Volumn 42, Issue 3, 2008, Pages 254-

  Sazhin, Vladimir ^a   Reznik, Robert ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CHOLESTEROL; CLOZAPINE; GLUCOSE; LIPID; NEUROLEPTIC AGENT; OLANZAPINE; TRIACYLGLYCEROL;

ADULT; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; DELUSION; GLUCOSE BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; LENGTH OF STAY; LETTER; LIPID ANALYSIS; LIPID BLOOD LEVEL; MALE; MENTAL DISEASE; PRISON; RISK FACTOR; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL; BIPOLAR DISORDER; FORENSIC PSYCHIATRY; HYPERLIPIDEMIA; PRISONER; PSYCHOLOGICAL ASPECT; STATISTICS;

ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; CARDIOVASCULAR DISEASES; DELUSIONS; FORENSIC PSYCHIATRY; HUMANS; HYPERLIPIDEMIAS; PRISONERS; RISK FACTORS; SCHIZOPHRENIA; SMOKING;

EID: 39049169023     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.1080/00048670701827283     Document Type: Letter

References (4)

1. Osborn, D., Nazareth, I. and King, M. (2006) Risk for coronary heart disease in people with severe mental illness. Cross-sectional comparative study in primary care. Br J Psychiatry, 188, pp. 271-277.
2. Mackin, P., Bishop, D., Watkinson, H., Gallagher, P. and Ferrier, N. (2007) Metabolic disease and cardiovascular risk in people treated with antipsychotics in the community. Br J Psychiatry, 191, pp. 23-29.
3. Liorente, M. and Urrutia, V. (2006) Diabetes, psychiatric disorders, and the metabolic effects of antipsychotic medications. Clin Diabetes, 24, pp. 18-24.
4. Alberti, KG, Zimmet, P. and Shaw, J. (2006) Metabolic syndrome: A new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med, 23, pp. 469-480.